MDR-TB and XDR-TB: Drug resistance and treatment outcomes

G. B. Migliori; G. Sotgiu; M. D'Arcy Richardson; R. Centis; A. Facchini; G. Guenther; A. Spanevello; C. Lange

doi:10.1183/09031936.00059409

MDR-TB and XDR-TB: Drug resistance and treatment outcomes

G. B. Migliori, G. Sotgiu, M. D'Arcy Richardson, R. Centis, A. Facchini, G. Guenther, A. Spanevello, C. Lange

Istituti Clinici Scientifici Maugeri Spa – Società Benefit

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	778-779
Number of pages	2
Journal	European Respiratory Journal
Volume	34
Issue number	3
DOIs	https://doi.org/10.1183/09031936.00059409
Publication status	Published - Sep 2009

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1183/09031936.00059409

Cite this

@article{d73466a2393940588233c8a1168d41a5,

title = "MDR-TB and XDR-TB: Drug resistance and treatment outcomes",

author = "Migliori, {G. B.} and G. Sotgiu and {D'Arcy Richardson}, M. and R. Centis and A. Facchini and G. Guenther and A. Spanevello and C. Lange",

year = "2009",

month = sep,

doi = "10.1183/09031936.00059409",

language = "English",

volume = "34",

pages = "778--779",

journal = "European Journal of Respiratory Diseases",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "3",

}

TY - JOUR

T1 - MDR-TB and XDR-TB

T2 - Drug resistance and treatment outcomes

AU - Migliori, G. B.

AU - Sotgiu, G.

AU - D'Arcy Richardson, M.

AU - Centis, R.

AU - Facchini, A.

AU - Guenther, G.

AU - Spanevello, A.

AU - Lange, C.

PY - 2009/9

Y1 - 2009/9

UR - http://www.scopus.com/inward/record.url?scp=70349147066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349147066&partnerID=8YFLogxK

U2 - 10.1183/09031936.00059409

DO - 10.1183/09031936.00059409

M3 - Article

C2 - 19720816

AN - SCOPUS:70349147066

VL - 34

SP - 778

EP - 779

JO - European Journal of Respiratory Diseases

JF - European Journal of Respiratory Diseases

SN - 0903-1936

IS - 3

ER -